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Ca2+-transcription coupling controls gene expression patterns that define vascular smooth muscle 
cell (VsMC) phenotype. Although not well understood this allows normally contractile VsMCs to 
become proliferative following vessel injury, a process essential for repair but which also contributes 
to vascular remodelling, atherogenesis and restenosis. Here we show that the Ca2+/HCo3−-sensitive 
enzyme, soluble adenylyl cyclase (sAC), links Ca2+ influx in human coronary artery smooth muscle 
cells (hCASMCs) to 3′,5′-cyclic adenosine monophosphate (cAMp) generation and phosphorylation 
of the transcription factor Ca2+/cAMp response element binding protein (CReB). store-operated Ca2+ 
entry (SOCE) into hCASMCs expressing the FRET-based cAMP biosensor H187 induced a rise in cAMP 
that mirrored cytosolic [Ca2+]. SOCE also activated the cAMP effector, protein kinase A (PKA), as 
determined by the PKA reporter, AKAR4-NES, and induced phosphorylation of vasodilator-stimulated 
phosphoprotein (VASP) and CREB. Transmembrane adenylyl cyclase inhibition had no effect on the 
SOCE-induced rise in cAMP, while sAC inhibition abolished SOCE-generated cAMP and significantly 
reduced soCe-induced VAsp and CReB phosphorylation. this suggests that soCe in hCAsMCs 
activates sAC which in turn activates the cAMp/pKA/CReB axis. sAC, which is insensitive to G-protein 
modulation but responsive to Ca2+, pH and Atp, may therefore act as an overlooked regulatory node in 
vascular Ca2+-transcription coupling.
In healthy blood vessels, the majority of vascular smooth muscle cells (VSMCs) are quiescent, contractile and 
proliferate slowly1. Quiescent VSMCs change to a synthetically active and proliferative phenotype in response 
to stimuli such as mechanical stress, growth factors or inflammatory mediators2. This plasticity is important for 
vessel repair at times of vascular injury, but is also a central feature of vascular disease. Proliferation of VSMCs in 
the vessel wall contributes to atherogenesis, vascular remodelling in pulmonary hypertension, and to restenosis, 
a narrowing of the vessel lumen following balloon angioplasty and bypass vein grafting3–5. The altered pattern of 
gene expression that drives changes in VSMC phenotype correlates with different patterns of Ca2+ signaling6,7, 
although the molecular basis of Ca2+-regulated gene expression in VSMCs is not well understood.
Ca2+-induced gene expression can be mediated in VSMCs by the transcription factor Ca2+/cyclic AMP 
response element binding protein (CREB)6. CREB binds as a dimer to a conserved cyclic AMP response element 
(CRE) in the promoter of pro-survival genes and activates transcription in response to a variety of diverse extra-
cellular signals8. Multiple Ca2+-regulated signaling cascades converge to phosphorylate CREB at a critical Ser133 
residue, which induces recruitment of coactivators and the formation of an active transcriptional complex9. Ser133 
is a substrate for a number of kinases that are either directly or indirectly activated by Ca2+, including protein 
kinase A (PKA), protein kinase C, members of the calcium/calmodulin-dependent kinase (CaMK) family and 
ribosomal S6 kinase (RSK) −26. Intriguingly, Ca2+ signals from different sources trigger different patterns of 
CRE-regulated VSM gene expression10. Voltage-dependent Ca2+ influx through L-type Ca2+ channels induces 
CREB phosphorylation in both cultured VSMCs and in intact mouse cerebral arteries11,12 and correlates with 
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an increase in transcription of proliferation-associated CRE-containing genes such as c-fos and early growth 
response-1, egr-110–12. In agreement with this, cerebral arteries from hypertensive rats are depolarized compared 
to normotensive animals and have elevated cytosolic Ca2+ and increased CREB phosphorylation/c-fos expres-
sion, which can be reversed by L-type Ca2+ channel inhibition13. Ca2+ influx in response to depletion of the 
sarcoplasmic reticulum (SR) Ca2+ stores (store-operated Ca2+ entry, SOCE) also activates CREB in both cultured 
VSMCs and intact arteries. Here, CREB activation leads to the transcription of a set of CRE-regulated genes that 
overlaps, but is distinct from, the genes expressed following L-type Ca2+ channel activation10,14. Several transient 
receptor potential (TRP) channels as well as the Ca2+ release-activated channel protein 1 (Orai1) and the SR Ca2+ 
sensor stromal interaction molecule 1 (STIM1) are expressed in VSM and may mediate SOCE15,16. Orai1 and 
STIM1 are both upregulated in response to vascular injury17 and are also required for the activation of CREB 
involved in VSMC proliferation18. In line with this, STIM1 knockdown decreases SOCE-induced CREB acti-
vation in human coronary artery SMCs and suppresses cell growth19. STIM2 is also upregulated in pulmonary 
artery hypertension, which raises basal Ca2+ levels and enhances pulmonary artery VSMC proliferation and vas-
cular remodelling at least partially through activation CREB20. Indeed, inhibition of Orai-mediated Ca2+ entry 
and the resultant suppression of Ca2+-transcription coupling has been suggested to underlie the anti-proliferative 
effects of stent-coating drug sirolimus (rapamycin) in human arteries21.
In cultured VSMCs CREB activation is associated with both pro-22–25, and anti-proliferative outcomes26,27, and 
this complex behaviour is also reflected in vivo. In rat models, phospho-CREB is elevated in neointimal VSMCs 
that appear after balloon injury of the carotid artery28, and increased phospho-CREB levels correlate with high 
proliferation rates in cerebral artery following several forms of vessel injury linked with susceptibility to stroke29. 
In contrast, analysis of arteries taken from bovine systemic and pulmonary circulation show a reverse correlation 
between CREB phosphorylation and proliferation, with phospho-CREB high in quiescent, contractile smooth 
muscle cells from the healthy vessel’s medial layer30. Here, chronic exposure of animals to lower than normal 
oxygen levels leads to increased VSMC proliferation in pulmonary vessels and decreased levels of both CREB 
and phospho-CREB30. This highlights our incomplete understanding of how different environmental cues are 
integrated by VSMCs to activate gene transcription.
The current model for PKA-mediated phosphorylation of CREB in VSMCs is that Ca2+ entering the cytosol 
binds to calmodulin (CaM) and that the Ca2+/CaM complex then activates Ca2+-sensitive transmembrane ade-
nylyl cyclases (tmACs), leading to generation of cyclic AMP and the activation of PKA8. An alternative source of 
cyclic AMP comes from soluble adenylyl cyclase (sAC), a novel enzyme that lacks the two hydrophobic domains 
that embed tmACs in the membrane and which thus distributes about the cell in regions remote from the plasma 
membrane31. Here, we demonstrate that SOCE activates sAC to generate cyclic AMP and induce phosphorylation 
of CREB at Ser133 in human coronary artery smooth muscle cells. sAC is insensitive to G-protein modulation and 
forskolin activation, but directly activated by Ca2+ (independently of CaM) and HCO3− and responds to physio-
logically relevant ATP concentrations32. Since CO2 is in equilibrium with HCO3− due to the activity of carbonic 
anhydrases, sAC functions as a CO2/HCO3−, and thus indirect, pH sensor. This ability to sense and integrate 
fluctuations in intracellular signals suggests sAC may be an important and overlooked regulatory node in the 
VSMC Ca2+-transcription pathway.
Results
soCe increases intracellular cyclic AMp and activates pKA in human coronary artery smooth 
muscle cells (hCAsMCs). To generate store-operated Ca2+ entry (SOCE), hCASMC internal Ca2+ stores 
were depleted by bathing fura-2-AM-loaded cells in nominally Ca2+-free solution for 10 minutes before addition 
of the sarcoplasmic reticulum Ca2+ ATPase (SERCA) inhibitor, thapsigargin (TG, 2 μM) to the same solution. 
Ca2+ leaks passively from the stores through permanently open leak channels and is subsequently removed from 
the cytosol either by extrusion across the plasma membrane or reuptake into the stores by SERCA. Inhibition of 
SERCA thus blocks reuptake and causes a transient rise in intracellular Ca2+ as leak Ca2+ briefly builds up in the 
cytosol before being moved out of the cell by plasma membrane Ca2+ ATPases (Fig. 1a). Over time this process 
depletes Ca2+ stores. Subsequent addition of Ca2+ (1.8 mM) to the extracellular solution induces a rapid rise 
in cytosolic Ca2+ due to SOCE (Fig. 1a). hCASMCs transduced with adenoviruses encoding the FRET-based 
cyclic AMP biosensor H187 and exposed to the same protocol exhibit changes in intracellular cyclic AMP that 
essentially mirror the cytosolic Ca2+ increase induced by the addition of thapsigargin and by SOCE (Fig. 1b). As 
a control, saturating concentrations of the transmembrane adenylyl cyclase activator, forskolin, (20 μM) and the 
pan-phosphodiesterase inhibitor, IBMX, (500 μM) were added at the end of each experiment to generate maximal 
cyclic AMP responses. These intracellular increases in cyclic AMP activated the major downstream cyclic AMP 
effector, protein kinase A (PKA). PKA activity was measured in real-time in hCASMCs transduced with ade-
noviruses encoding the PKA reporter, AKAR4-NES (Fig. 1c). PKA activity was also monitored by immunoblot 
to determine the phosphorylation status of multiple PKA substrates (PKA substrate antibody detects proteins 
containing a phospho-Ser/Thr residue within the PKA recognition motif Arg-Arg-X-Ser/Thr) and of the specific 
PKA substrate, vasodilator-stimulated phosphoprotein (VASP)33,34 (Fig. 1d).
soCe-generated cyclic AMp is abolished by acute inhibition of soluble adenylyl cyclase. The 
Ca2+ sensitivity of some isoforms of the enzyme adenylyl cyclase is a well-defined mechanism linking Ca2+ influx 
to the generation of cyclic AMP35. Mammals express nine transmembrane isoforms of adenylyl cyclase (tmAC1-
9) and one soluble isoform (sAC; AC10), which are differentially regulated by Ca2+ 36. Of the tmACS, AC5 and 
AC6 are inhibited by sub-micromolar concentrations of Ca2+ while AC1 and AC8, and to a lesser extent AC3, 
are stimulated by Ca2+ via CaM binding36. Consistent with other findings37–39, reverse transcription-PCR, using 
cDNA derived from hCASMCs as a template and primers designed to detect AC isoforms 1–10, confirmed the 
presence of transcripts for AC3, 4, 6, 7, 9 and 10 (Fig. 2a). Since AC3 has been reported to be weakly activated 
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by Ca2+/CaM40 we tested the effect of acutely inhibiting tmACs on the SOCE-generated cyclic AMP. 2′-5′ dide-
oxyadenosine (DDA) is a well-characterised cell-permeable pharmacological tool for distinguishing between 
tmACs and sAC. In whole-cell lysates DDA inhibits tmACs with an IC50 of ~10 μM and sAC with an IC50 of over 
500 μΜ41. Preincubation of hCASMCs in DDA (100 μM) significantly reduced the transient increase in cyclic 
AMP seen upon addition of thapsigargin, but had no effect on SOCE-generated cyclic AMP (Fig. 2b). In parallel 
control experiments, addition of DDA (100 μM) induced a significant reduction in cyclic AMP generated in 
response to prostacyclin (PGI2; 1 nM, Fig. 2c). Pre-incubation with the catechol estrogens, 2-hydroxyestradiol 
(2-CE, 20 μM) or 4-hydroxyestradiol (4-CE, 20 μM), which in cell-based systems are selective sAC inhibitors41, 
completely abolished generation of cyclic AMP in response to both the addition of thapsigargin and SOCE 
(Fig. 2d,e). Aside from effects on sAC, 2CE and 4CE could potentially block the production of cyclic AMP by 
Figure 1. SOCE increases intracellular cyclic AMP and activates PKA in human coronary artery smooth 
muscle cells (hCASMCs). (a) Intracellular Ca2+ measurements recorded in fura-2-AM-loaded hCASMCs. Cells 
were initially bathed in nominally Ca2+-free solution for 10 minutes before treatment with thapsigargin (TG, 
2 μM). Ca2+ (1.8 mM) was then introduced into the extracellular solution and was present hereafter (n = 54 
from 4 experimental repeats). (b) Intracellular cyclic AMP levels measured in hCASMCs transduced with 
adenoviruses encoding the cyclic AMP biosensor H187 (upper panel, see Methods for details) and subjected 
to the same experimental scheme as described in (a). At the end of the experiment saturating concentrations 
of forskolin (20 μM) and IBMX (500 μM) were added to generate maximal cyclic AMP responses (n = 20 
cells from 4 experimental repeats). (c) PKA activity measured in hCASMCs transduced with adenoviruses 
encoding the PKA reporter, AKAR4-NES (upper panel, see Methods for details) in response to the experimental 
scheme described in a (n = 19 cells from 4 experimental repeats). All extracellular solutions contain 1% serum. 
Error bars represent the standard error of the mean. (d) Western blot analyses of hCASMC homogenates 
immunoblotted with anti-VASP (upper panel) and anti-phospho-PKA substrates (lower panel). Before being 
lysed, cells were exposed to either: vehicle control (0.1% DMSO); thapsigargin (TG, 2 μM) for 5 min in zero 
extracellular Ca2+, TG for 5 min in zero extracellular Ca2+ followed by introduction of 1.8 mM extracellular 
Ca2+ for a further 5 min; or forskolin (20 μM) plus IBMX (500 μM) for 5 min. In lysates immunoblotted 
with anti-VASP, phosphorylated VASP appears as a slower-migrating band. Maximal phosphorylation is 
seen following exposure to saturating concentrations of forskolin and IBMX. Blots shown representative of 
3 experimental repeats. (e) Densiometric analysis; the density of the phospho-VASP immunoreactive band 
relative to the lower (unphosphorylated) VASP band (n = 3, Control vs TG/0Ca2+: P = 0.024; Control vs 
TG/1.8Ca2+: P = 0.026; Control vs Fsk/IBMX: P = 0.001; one-way ANOVA with Student Newman Keuls post-
hoc test).
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inhibiting Ca2+ entry into the cell. Since 2CE has previously been shown to inhibit voltage-gated Ca2+ influx in 
pig coronary arteries42, we assessed the effects of 2CE and 4CE on SOCE. Exposure of hCASMCs to either 2CE or 
4CE did not inhibit Ca2+ entry following thapsigargin-induced store depletion and the reintroduction of extra-
cellular Ca2+ (Fig. 2f).
Inhibition of soluble adenylyl cyclase abolishes soCe-induced VAsp phosphorylation. In line 
with our FRET-based studies, pre-incubation of cells with 2CE (20 μM) or 4CE (20 μM) significantly reduced 
SOCE-induced phosphorylation of VASP (Fig. 3a,b). For these experiments, we exposed hCASMCs to the 
thapsigargin-induced store depletion/Ca2+ reintroduction protocol (Figs 1, 2) in the presence or absence of AC 
inhibitors, lysed cells and analysed lysates by immunoblot using antibodies against VASP. We also tested the 
effects of KH7, a selective inhibitor of sAC with intrinsic fluorescence that makes it unsuitable for use in flu-
orescent microscopy. In whole cell lysates KH7 inhibits sAC with an IC50 of 20 μM while having no significant 
effect on tmAC activity at concentrations up to 1 mM41. Pre-incubation with KH7 (20 μM) significantly reduced 
Figure 2. SOCE-generated cyclic AMP is abolished by inhibition of soluble adenylyl cyclase. (a) Primers 
designed to amplify adenylyl cyclase isoforms (1–10) were used to probe hCASMC cDNA. PCR products 
were separated on a 3% agarose gel. (b–e) hCASMCs transduced with adenoviruses encoding the cyclic 
AMP biosensor H187 and subjected to the same experimental scheme as described in Fig. 1. Cells were pre-
incubated in either vehicle control (0.1% DMSO; black all traces); the transmembrane adenylyl cyclase inhibitor 
2′-5′ dideoxyadenosine (DDA, 100 μM, n = 48 from 4 experimental repeats, (b)) or soluble adenylyl cyclase 
inhibitors 2-hydroxyestradiol (2-CE, 20 μM, n = 29 from 4 experimental repeats (d)) or 4-hydroxyestradiol 
(4-CE, 20 μM, n = 18 from 4 experimental repeats, (e)) for at least 10 minutes before addition of thapsigargin 
(TG, 2 μM). Inhibitors were then present until addition of forskolin (20 μM) and IBMX (500 μM) and the 
paired controls were conducted on the same day as the test. (c) As a positive control, addition of DDA (100 μM) 
induced a significant reduction in cyclic AMP generated in response to prostacyclin (PGI2; 1 nM, n = 24 from 
4 experimental repeats). Error bars represent the standard error of the mean. (f) Store-operated Ca2+ entry 
recorded in Fluo-4AM-loaded hCASMCs under control conditions and in the presence of either 2-CE and 
4-CE (20 μM). Cells were initially bathed in nominally Ca2+-free solution for 10 minutes before treatment with 
thapsigargin (TG, 2 μM). Ca2+ (1.8 mM) was then introduced into the extracellular solution (control, n = 90 
cells; 2-CE, n = 65 cells; 4-CE, n = 89 cells). Error bars represent the standard error of the mean.
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SOCE-induced VASP phosphorylation (Fig. 3c,d). The effect of DDA (100 μM) on SOCE-induced VASP phos-
phorylation did not reach significance.
Cyclic AMp generated by soluble adenylyl cyclase in response to soCe phosphorylates CReB. 
To assess the downstream consequences of SOCE-generated cyclic AMP, we also analysed hCASMC lysates 
by immunoblot using antibodies specific to CREB’s Ser133 phospho-site (Fig. 4). Figure 4a,c (lanes 1–2) shows 
that thapsigargin-induced store depletion followed by addition of Ca2+ (1.8 mM) to the extracellular solution 
induces significant phosphorylation of CREB at Ser 133. Pre-incubation with the catechol estrogens 2CE and 4CE 
(Fig. 4a,b), or KH7 (Fig. 4c,d), significantly reduced SOCE-induced CREB phosphorylation.
Discussion
Our data suggest that Ca2+ influx in response to hCASMC store depletion activates the Ca2+ and HCO3−-sensitive 
enzyme, sAC, which generates cyclic AMP to activate PKA/CREB. Intracellular cyclic AMP levels in hCASMCs 
largely mirrored the changes in cytosolic free Ca2+ seen during thapsigargin-induced store depletion and sub-
sequent SOCE. Inhibition of tmACs significantly reduced the intracellular increases in cyclic AMP seen during 
thapsigargin-induced store depletion, but had no significant effect on SOCE-generated cyclic AMP. In agreement 
with other studies, we found no evidence for expression of the Ca2+-activated AC1 or AC8 in these cells, although 
we did find transcripts for AC3, which is weakly activated by Ca2+ (half-maximal activation 5 μM)40. Acute inhibi-
tion of sAC abolished the intracellular increases in cyclic AMP seen during thapsigargin-induced store depletion 
and subsequent SOCE, suggesting that activation of sAC is a prerequisite for cyclic AMP generation via both 
Figure 3. Inhibition of soluble adenylyl cyclase abolishes SOCE-induced VASP phosphorylation. Immunoblot 
blot analyses of hCASMC homogenates immunoblotted with anti-VASP and anti-GAPDH (loading control). 
Before being lysed, cells were exposed to either: vehicle control (0.1% DMSO, Lane 1 both blots) or thapsigargin 
(TG, 2 μM) for 5 min in zero extracellular Ca2+ followed by introduction of 1.8 mM extracellular CaCl2 for 
a further 5 min (Lane 2 both blots). (a) Cells in Lane 3–5 were exposed to the same protocol as Lane 2, with 
the exception that they were pre-incubated in either DDA (100 μM; Lane 3), 2-CE (20 μM; Lane 4) or 4-CE 
(20 μM; Lane 5) for 15 minutes before exposure to TG. (c) Cells in Lane 3–4 were exposed to the same protocol 
as Lane 2, with the exception that they were pre-incubated in either KH7 (20 μM; Lane 3) or DDA (100 μM; 
Lane 4) for 15 minutes before exposure to TG. Inhibitors were then present throughout the experiment. The 
final lane in both blots is a positive control where cells were exposed to saturating concentrations of forskolin 
(20 μM) and IBMX (500 μM) only. Proteins within the homogenates were separated on 10% polyacrylamide-
Tris gels. Phosphorylated VASP appears as a slower-migrating band in the upper panel (a,c). Blots shown 
representative of 3 experimental repeats. (b) Densiometric analysis of experiments shown in a; the density of 
the phospho-VASP immunoreactive band relative to the lower (unphosphorylated) VASP band (n = 3, Control 
vs TG/1.8Ca2+: P = 0.011; TG/1.8Ca2+ vs DDA/TG/1.8Ca2+: P = 0.892; TG/1.8Ca2+ vs 2CE/TG/1.8Ca2+: 
P = 0.030; TG/1.8Ca2+ vs 4CE/TG/1.8Ca2+: P = 0.026; one-way ANOVA with Student Newman Keuls post-hoc 
test). (d) Densiometric analysis of experiments shown in c; the density of the phospho-VASP immunoreactive 
band relative to the lower (unphosphorylated) VASP band (n = 3, Control vs TG/1.8Ca2+: P = 0.03; TG/1.8Ca2+ 
vs KH7/TG/1.8Ca2+: P = 0.037; TG/1.8Ca2+ vs DDA/TG/1.8Ca2+: P = 0.064 one-way ANOVA with Student 
Newman Keuls post-hoc test).
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processes. To our knowledge, SOCE has not previously been reported to activate sAC, although Ca2+ influx 
through voltage-gated Ca2+ channels activates sAC in insulinoma cells43.
By using biosensors to monitor real-time changes in the activity of the major cyclic AMP effector, PKA, 
our data also show that SOCE/sAC-generated cyclic AMP activates PKA. This induces phosphorylation of a 
number of PKA substrates within the cell, including VASP and the transcription factor, CREB. Previous studies 
have shown that Ca2+ influx through store-operated channels activates CREB and induces transcription of a 
distinct set of genes in VSMCs10, but the pool of cyclic AMP responsible for PKA-mediated CREB activation 
was believed to be generated exclusively by tmACs. More recent work shows that CREB can mediate both pro- 
and anti-mitogenic responses in VSMCs dependent upon different modes of activation44. Activation of CREB 
by cyclic AMP generated by either forskolin or agonists at G protein-coupled receptors (both of which exclu-
sively activate tmACs) is independent of Ser133 phosphorylation but dependent on nuclear translocation of CREB 
Regulated Transcription Coactivators (CRTCs)44,45. This form of CREB activation is anti-proliferative. In contrast, 
stimulation of VSMCs by mitogens significantly increases CREB activity via Ser133 phosphorylation but not CRTC 
activation. CREB activated by this mechanism induces pro-mitogenic responses since CREB silencing under 
these circumstances inhibits basal and growth factor-induced proliferation44. Our studies, which were conducted 
in the presence of serum and show Ser133 phosphorylation, suggest that sAC-generated cyclic AMP may contrib-
ute to this latter pro-proliferative pathway.
Compared to the relatively well-studied tmACs, our knowledge of the role of sAC in the vasculature is limited. 
Although widely expressed throughout the cardiovascular system46, the only previously reported role for vascular 
sAC involves activation by oxidative stress to promote the intrinsic apoptotic pathway47. Similar roles in apoptotic 
signaling have been described in coronary endothelial cells48 and cardiomyocytes49. In cardiomyocytes there is 
evidence of roles for sAC outside of death pathways in the development of cardiac hypertrophy50, and in match-
ing energy production to nutrient levels in mitochondria51. Here, CO2/HCO3− generated by the citric acid cycle 
activates sAC localized in the matrix to produce cyclic AMP, which mediates a PKA-dependent increase in the 
activity of the electron transport chain and oxidative phosphorylation51,52. A source of cyclic AMP that is distinct 
Figure 4. Cyclic AMP generated by sAC in response to SOCE phosphorylates CREB. Immunoblot analyses of 
hCASMC homogenates immunoblotted with antibodies specific to the Ser133 phospho-site on CREB (pCREB), 
total CREB and smooth muscle α actin (loading control). Before being lysed, cells were exposed to either: 
vehicle control (0.1% DMSO, Lane 1 both blots) or thapsigargin (TG, 2 μM) for 5 min in zero extracellular 
Ca2+ followed by introduction of 1.8 mM extracellular CaCl2 for a further 5 min (Lane 2 both blots). (a) Cells 
in Lane 3–4 were exposed to the same protocol as Lane 2, with the exception that they were pre-incubated in 
2-CE (20 μM; Lane 3) or 4-CE (20 μM; Lane 4) for 15 minutes before exposure to TG. (c) Cells in Lane 3 were 
exposed to the same protocol as Lane 2, with the exception that they were pre-incubated in KH7 (20 μM) for 
15 minutes before exposure to TG. Inhibitors were then present throughout the experiment. The final lane in 
both blots is a positive control where cells were exposed to saturating concentrations of forskolin (20 μM) and 
IBMX (500 μM) only. Proteins within the homogenates were separated on 10% polyacrylamide-Tris gels. Blots 
shown representative of at least 3 experimental repeats. (b) Densiometric analysis of experiments shown in 
a; the relative density of the phospho-CREB immunoreactive band (n = 3, Control vs TG/1.8Ca2+: P = 0.010; 
TG/1.8Ca2+ vs 2CE/TG/1.8Ca2+: P = 0.048; TG/1.8Ca2+ vs 4CE/TG/1.8Ca2+: P = 0.023; one-way ANOVA with 
Student Newman Keuls post-hoc test). (d) Densiometric analysis of experiments shown in c; the relative density 
of the phospho-CREB immunoreactive band (n = 6, Control vs TG/1.8Ca2+: P = 0.018; TG/1.8Ca2+ vs KH7/
TG/1.8Ca2+: P = 0.014; one-way ANOVA with Student Newman Keuls post-hoc test).
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from the G-protein-responsive plasma membrane-localized tmACs is likely to be an important general feature in 
signaling. Cyclic AMP has a limited diffusion distance largely due to the action of phosphodiesterases that restrict 
its spread throughout the cell to ensure the fidelity of signal transfer to intended targets53. sAC is able to locate 
to several intracellular compartments, including the cytosol, the nucleus54, and the mitochondria51,55. Indeed, in 
skin cells, sAC localizes to the nucleus where it complexes with CREB56. Zippin et al. demonstrated the existence 
of a functional signaling complex consisting of sAC, the PKA holoenzyme and CREB in the nucleus of human 
cell lines and in a subpopulation of rat liver cells54. This complex ensures rapid CREB activation in response to 
changes in HCO3− and was distinct from the slower hormone or neurotransmitter CREB activation via tmACs.
In conclusion, our data suggest that in hCASMCs SOCE activates the Ca2+ and HCO3−-sensitive sAC, which 
generates cyclic AMP to activate the PKA/CREB axis. Being located away from the plasma membrane may allow 
sAC access to pools activators and effectors that are distinct from the membrane-confined tmAC microdomains. 
This coupled with its ability to respond rapidly to changes in the intracellular environment suggests it may act as 
a regulatory point in VSMC Ca2+-transcription coupling. Although the functional consequences of sAC-induced 
CREB phosphorylation are undetermined, recent evidence suggests it may link to pro-mitogenic responses in 
VSMCs44. A single gene encodes sAC, which is widely expressed in mammalian tissues31. Alternative splicing 
generates multiple sAC isoforms57, suggesting that VSMC sAC may warrant investigation as a potentially novel 
drug target for proliferative vascular disease. It will also be important to determine if specific subsets of phos-
phodiesterases control the dispersal of sAC-generated cyclic AMP in VSMCs as these ‘druggable’ targets may offer 
an additional route to manipulate the signaling pathway.
Materials and Methods
Chemicals. 2′-5′dideoxyadenosine (DDA) and thapsigarin were purchased from Merck Millipore (Watford, 
UK). (6)-2-(1H-benzimidazol-2-ylthio)propanoic acid 2-[(5-bromo-2-hydroxyphenyl)methylene]hydrazide 
(KH7) and forskolin were purchased from Tocris Bioscience (Abingdon, UK). Fura-2-AM and Fluo-4 AM were 
purchased from ThermoFisher Scientific (Paisley, UK). All other chemicals, including 2-hydroxyestradiol (2-CE), 
4-hydroxyestradiol (4-CE), and 3-isobutyl-1-methylxanthine (IBMX) were purchased from Sigma Aldrich 
(Gillingham, UK).
Cell culture. Human coronary artery smooth muscle cells (hCASMCs; Promocell, Heidelberg, Germany) 
were cultured in smooth muscle cell growth medium 2 containing 5% (v/v) foetal calf serum supplemented 
with basic fibroblast growth factor (2 ng mL−1), epidermal growth factor (0.5 ng mL−1) and insulin (5 μg mL−1; all 
Promocell). Cells between passages 6–12 were cultured in a humidified incubator at 37 °C and 5% CO2 atmos-
phere, with culture media changed every 2–3 days. Cells were routinely sub-cultured at 70–80% confluency.
Adenovirus transduction. Adenoviruses encoding H187 [AD(RGD)-CMV-H187] and AKAR4 
[AD(RGD)-CMV-AKAR4-NES] were cloned, packaged, amplified and titrated by Vector Biosystems Inc 
(Malvern, PA, USA). For FRET-based imaging studies, viral particles of either AD(RGD)-CMV-H187 or 
AD(RGD)-CMV-AKAR4-NES in a solution containing Dulbecco’s Modified Eagle Medium (DMEM; Gibco 
ThermoFisher Scientific), 2% (w/v) bovine serum albumin (BSA; Invitrogen, ThermoFisher Scientific) and 2.5% 
(v/v) glycerol, were added directly to hCASMC suspensions at 10 MOI (multiplicity of infection). Cells were then 
seeded onto glass-bottomed culture dishes (Mattek Inc., Bratislava, Slovakia) for imaging 24 or 48 hours later.
Förster resonance energy transfer (FRet)-based biosensors and fluorescence imaging. 
Real-time cyclic AMP changes were measured in live hCASMCs transduced with adenoviruses encoding the 
biosensor H187 (mTurquoise2Δ-Epac(CD,ΔDEP,Q270E)-tdcp173Venus; plasmid used for adenoviral con-
struction a gift from Kees Jalink, Univ of Amsterdam, Netherlands)58. This sensor consists of the cAMP effec-
tor Epac1 fused to a cyan fluorescent protein (CFP) donor (mTurquoise2) and an optimized yellow fluorescent 
protein (YFP) acceptor (a tandem of the circular permutated version of Venus, cp173Venus). Binding of cAMP 
causes a conformational change resulting in a loss of energy transfer between the two fluorophores that can be 
detected as an increase in the CFP/YFP fluorescence ratio. To prevent construct enzymatic activity affecting 
downstream effectors, Epac has been rendered catalytically dead (CD) and a membrane-targeting domain is 
deleted (ΔDEPmutant) to allow measurement of cAMP in the bulk cytosol. Real-time PKA catalytic activity 
was measured in hCASMCs using the FRET-based PKA reporter A-Kinase Activity Reporter-Nuclear Export 
Signal, AKAR4-NES59 (a gift from Jin Zhang, John Hopkins University, Baltimore, USA). AKAR4 contains a PKA 
substrate and a phospho-amino acid binding domain (PAABD) between the FRET pair Cerulean and Venus. 
The PAABD binds to the PKA substrate when it is phosphorylated by active PKA, causing a decrease in distance 
between the fluorophores and an increase in FRET. Prior to each experiment, H187 and AKAR4-expressing 
hCASMCs were rinsed twice in a Na+-HEPES-based solution containing (mM): 140 NaCl, 4.7 KCl, 1.13 MgCl2, 
10 HEPES, and 10 glucose (all purchased from Sigma Aldrich); adjusted to pH 7.4 (referred to as HEPES solution 
hereafter). This HEPES solution was also supplemented with 1% (v/v) foetal calf serum (0.4 ng mL−1), epidermal 
growth factor (0.1 ng mL−1), insulin (1 μg mL−1) and 1.8 mM CaCl2 unless stated otherwise. All test solutions, 
including controls, were made using this HEPES solution.
Cells were imaged using an Olympus IX71 based inverted imaging system (Till Photonics GmbH, Germany). 
Excitation of fluorescence was provided by a 150 W xenon high stability lamp and a polychrome V monochro-
mator wavelength control (Till Photonics GmbH, Germany). Emission light was collected using band or high 
pass filters and sent to an iXon DV885 cooled EM CCD camera (Andor technology, UK). Camera binning was 
set to 2 both horizontally and vertically which provided 512 × 512 pixel points per image. TillVision software 
(Till Photonics, Germany) was used to control the parameters of image acquisition and selection of regions 
of interest, and allowed for the measurement of fluorescence while the experiment was in progress. H187 and 
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AKAR4-expressing hCASMCs were both excited at 405 nm, close to the excitation maximum of the donor, CFP. 
Emissions of both CFP and YFP fluorescence were measured simultaneously using an Optical Insights Dual-View 
Filter cube with D480 + 30 m and D535 + 40 m Filter Sets, (BioVision Technologies, USA) which only allows 
emission wavelengths of 480 nm and 535 nm to reach the camera. During each experiment non-fluorescent cells 
or regions containing no cells were used as background fluorescence from which the reading was subtracted.
Ca2+ fluorimetry. hCASMCs were incubated in 5 µM of the ratiometric Ca2+ dye Fura-2 AM dissolved in 
HEPES solution for 1 hour at room temperature in the dark. Fura-2 AM-loaded cells were then rinsed twice with 
HEPES solution, before being placed into the perfusion chamber for live cell imaging using the Olympus IX71 
based inverted imaging system (above). The cell was illuminated alternately with 340 and 380 nm light (bandpass 
5 nm) and the emission signal was detected at 510 nm (40 nm bandpass). Temporal change in photon counts was 
measured, backgrounds were subtracted, and the complete ratio was obtained at 50 Hz. As in FRET experiments, 
cells that were not fluorescent or regions containing no cells were used as background from which the reading was 
subtracted. For indicated experiments, cells were incubated with 5 µM Fluo-4 AM in glass-bottomed dishes (Ibidi 
GmbH, Germany), washed as described above and imaged using a Zeiss LSM 710 confocal microscope. Cells 
were excited with 488 nm light and the emission signal was detected within a range of 493–622 nm.
sDs-pAGe and Immunoblotting. hCASMCs were seeded onto 6-well plates and allowed to grow at 37 °C 
and 5% CO2 atmosphere until 70–80% confluence. Cells were then incubated in vehicle control (0.1% DMSO) 
or incubated in zero extracellular Ca2+ for 5 mins before being treated with thapsigargin (TG, 2 μM) for 5 min in 
zero extracellular Ca2+ followed by introduction of 1.8 mM extracellular CaCl2 for a further 5 min. As a positive 
control cells were exposed to saturating concentrations of forskolin (20 μM) and IBMX (500 μM) only. In some 
experiments, cells were incubated in the tmAC inhibitor DDA (100 μM) or the sAC inhibitors KH7 or 2CE or 
4CE (20 μM) for at least 15 minutes before TG treatment. Inhibitors were then present throughout the exper-
iment. The solution used for all treatments was the same supplemented HEPES solution used for fluorescent 
imaging. Following each treatment, cells were then lysed in ice-cold radioimmunoprecipitation assay (RIPA) 
buffer containing 1% (v/v) protease inhibitor cocktail and 1x PhosSTOP phosphatase inhibitor cocktail (both 
Sigma-Aldrich). The resultant lysates were rotated for 15 minutes at 4 °C and then centrifuged at 18,220 × g for 
15 minutes at 4 °C. Resultant supernatants were mixed 1:3 (v/v) with 4x sodium dodecyl sulfate-polyacrylamide 
(SDS) sample buffer, before heating to 98 °C for 10 minutes. Protein concentrations were quantified using 
a PierceTM BCA Protein Assay Kit (Thermofisher Scientific). Samples were kept at −20 °C until use. Proteins 
within the lysates were resolved by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) on 10–15% polyacryla-
mide gels and transferred electrophoretically onto nitrocellulose membranes (Hybond ECL, GE Healthcare). 
Immunoblotting was performed as previously described60.
Antibodies. For immunoblotting the primary antibodies used were against: total CREB, vasodilator-stimulated 
phosphoprotein (VASP) and phospho-PKA substrates (RRXS*/T*); all purchased from Cell Signaling 
Technologies (Hitchin, UK) and used at a dilution of 1:1000. Anti-smooth muscle α actin (dilution 1:10,000) was 
from Sigma-Aldrich. Anti-phospho-CREB (Ser133, dilution 1:1000) and anti-GAPDH (1: 2000) were purchased 
from Abcam (Cambridge, UK). The secondary antibodies used were: anti-mouse IgG (H + L) horseradish per-
oxidase (HRP) conjugated polyclonal antibody and anti-rabbit IgG (H + L) HRP conjugated polyclonal antibody 
(Stratech Scientific Ltd., Newmarket, U.K.), both used at a dilution of 1:5000.
Total RNA extraction and reverse transcription. Total RNA extraction and reverse transcription was 
carried out as previously described61.
polymerase chain reaction (pCR). Touchdown PCR was carried out as previously described61. Primers 
used to amplify specific adenylyl cyclase isoforms were previously published62. Products were analysed by run-
ning on a 3% agarose gel containing Midori Green (1:10,000; GC Biotech) for ~1 hour at 80 V. Bands were excised 
under ultraviolet light and products purified using a QIAquick Gel Extraction Kit (Qiagen) according to manu-
facturer’s instructions. All products were verified by sequencing (GATC Biotech, Germany).
statistical analysis. Statistical tests stated throughout. Results are expressed as the mean ± standard error 
of mean. For real-time Ca2+/cyclic AMP measurements, n numbers indicate number of cells from at least 3 
experimental repeats conducted on separate days. For immunoblots n numbers indicate number of experimental 
repeats.
Data Availability
The datasets generated during and/or analysed during the current study are available from the corresponding 
author on reasonable request.
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